Latest Brand Awareness News

RLF AgTech Ltd has closed FY2025 with a remarkable 74% increase in customer receipts and positive operating cash flow, underpinned by a comprehensive restructuring and renewed market momentum across Australia, China, and Asia.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

Immuron Limited reports a robust 49% increase in FY25 global sales of its immune supplement Travelan, driven by strong growth in Australia and North America. The company plans to accelerate its North American market presence in FY26.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

The Calmer Co. International Limited has significantly expanded the distribution of its flagship kava products in Coles supermarkets, reflecting growing consumer appetite for natural relaxation alternatives to alcohol.

Baby Bunting Group unveils its ambitious ‘Store of the Future’ strategy, targeting a return to double-digit EBITDA margins through store refurbishments, new small format pilots, and enhanced omni-channel capabilities. The company sets FY25 NPAT guidance between $10 million and $12.5 million, underpinned by a 40% gross margin target.

Baby Bunting reports a 2.9% year-to-date comparable store sales growth and opens an innovative new store format in Melbourne, raising its FY25 NPAT guidance amid strong early results.

Australian Dairy Nutritionals Limited reported a record $736k revenue from nutritional powders in Q3 FY25, driven by its new Future brand launch in China and expanding sales in Vietnam. The company’s strategic partnerships and premium product positioning signal a pivotal shift in its growth trajectory.

Oakridge International Limited reported strong operational and financial progress for Q1 2025, highlighting increased trading income, positive cash flow, and a robust sales pipeline in healthcare IoT technology despite ongoing legal discussions.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Mad Paws Holding Limited reported a robust 22% year-on-year growth in Gross Merchandise Value over March-April 2025, driven by marketplace momentum despite a 6% decline in group operating revenue. Strategic marketing campaigns and operational enhancements underpin the company’s growth trajectory.

Mad Paws Holdings Limited reported a resilient Q3 FY25 with an 8% rise in Group Cash EBITDA despite a 6% dip in operating revenue, driven by marketplace strength and a major new brand campaign.